Morgan Stanley’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.07M | Buy |
|
|||||
|
2025
Q1 | $3.44M | Sell |
|
|||||
|
2024
Q4 | $3.69M | Sell |
|
|||||
|
2024
Q3 | $4M | Buy |
|
|||||
|
2024
Q2 | $3.89M | Buy |
|
|||||
|
2024
Q1 | $3.76M | Sell |
|
|||||
|
2023
Q4 | $5.92M | Buy |
|
|||||
|
2023
Q3 | $2.18M | Buy |
|
|||||
|
2023
Q2 | $2.31M | Sell |
|
|||||
|
2023
Q1 | $3.83M | Sell |
|
|||||
|
2022
Q4 | $5.47M | Sell |
|
|||||
|
2022
Q3 | $6.07M | Buy |
|
|||||
|
2022
Q2 | $3.56M | Sell |
|
|||||
|
2022
Q1 | $6.41M | Sell |
|
|||||
|
2021
Q4 | $16.3M | Buy |
|
|||||
|
2021
Q3 | $3.91M | Buy |
|
|||||
|
2021
Q2 | $6.5M | Buy |
|
|||||
|
2021
Q1 | $3.24M | Sell |
|
|||||
|
2020
Q4 | $10.5M | Buy |
|
|||||
|
2020
Q3 | $1.81M | Sell |
|
|||||
|
2020
Q2 | $8.45M | Sell |
|
|||||
|
2020
Q1 | $12.7M | Sell |
|
|||||
|
2019
Q4 | $15.7M | Buy |
|
|||||
|
2019
Q3 | $9.82M | Sell |
|
|||||
|
2019
Q2 | $9.13M | Sell |
|
|||||
|
2019
Q1 | $15.6M | Buy |
|
|||||
|
2018
Q4 | $16M | Buy |
|
|||||
|
2018
Q3 | $3.85M | Buy |
|
|||||
|
2018
Q2 | $2.31M | Buy |
|
|||||
|
2018
Q1 | $2.46M | Buy |
|
|||||
|
2017
Q4 | $2.68M | Buy |
|
|||||
|
2017
Q3 | $2.16M | Sell |
|
|||||
|
2017
Q2 | $2.94M | Buy |
|
|||||
|
2017
Q1 | $2.47M | Sell |
|
|||||
|
2016
Q4 | $3.91M | Buy |
|
|||||
|
2016
Q3 | $987K | Sell |
|
|||||
|
2016
Q2 | $745K | Buy |
|
|||||
|
2016
Q1 | $147K | Buy |
|
|||||
|
2015
Q4 | $98K | Buy |
|
|||||
|
2015
Q3 | $61K | Sell |
|
|||||
|
2015
Q2 | $281K | Buy |
|
|||||
|
2015
Q1 | $207K | Sell |
|
|||||
|
2014
Q4 | $2.62M | Buy |
|
|||||
|
2014
Q3 | $2.19M | Buy |
|
|||||
|
2014
Q2 | $214K | Buy |
|